Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Di Maio

Showing results (1-10 of 418) with videos related to

Pageof 42
Sort By:
Expert Opinion on Biological Therapy|August 3, 2011
Is there still room for large registrative trials in unselected cancer patients? The case of anti-epidermal growth factor receptor antibodies in advanced non-small-cell lung cancerMassimo Di Maio
Recenti Progressi in Medicina|March 12, 2020
[Could a medication management app help people to optimize their oral cancer drugs intake?]Massimo Di Maio
Cancer Investigation|April 21, 2023
The Value of Patient-Reported Outcomes in Single-Arm Cancer TrialsMassimo Di Maio
Recenti Progressi in Medicina|November 18, 2020
[Outcomes reported by the patient: a tool for respecting the patient's rights and for involvement in research.]Massimo Di Maio
Recenti Progressi in Medicina|January 4, 2018
[Let's go forward, but wisely…]Massimo Di Maio
Expert Review of Anticancer Therapy|March 25, 2016
Platinum-based chemotherapy in advanced non-small-cell lung cancer: optimal number of treatment cyclesAntonio Rossi, Massimo Di Maio
Health and Quality of Life Outcomes|October 4, 2003
Quality of Life in elderly patients with cancerMassimo Di Maio, Francesco Perrone
Journal of Thoracic Disease|June 29, 2018
A review of guidelines for lung cancerPaolo Bironzo, Massimo Di Maio
Expert Opinion on Pharmacotherapy|January 8, 2010
The role of pemetrexed as maintenance treatment in advanced NSCLC: a Phase III randomized trialCesare Gridelli, Massimo Di Maio
Med (New York, N.Y.)|April 12, 2025
eNRGy: Making progress toward a future for NRG1 fusion-positive cancerLucia Anna Muscarella, Massimo Di Maio
Pageof 42

Showing results (1-10 of 418) with videos related to

Sort By:
Pageof 42
Expert Opinion on Biological Therapy|August 3, 2011
Is there still room for large registrative trials in unselected cancer patients? The case of anti-epidermal growth factor receptor antibodies in advanced non-small-cell lung cancerMassimo Di Maio
Recenti Progressi in Medicina|March 12, 2020
[Could a medication management app help people to optimize their oral cancer drugs intake?]Massimo Di Maio
Cancer Investigation|April 21, 2023
The Value of Patient-Reported Outcomes in Single-Arm Cancer TrialsMassimo Di Maio
Recenti Progressi in Medicina|November 18, 2020
[Outcomes reported by the patient: a tool for respecting the patient's rights and for involvement in research.]Massimo Di Maio
Recenti Progressi in Medicina|January 4, 2018
[Let's go forward, but wisely…]Massimo Di Maio
Expert Review of Anticancer Therapy|March 25, 2016
Platinum-based chemotherapy in advanced non-small-cell lung cancer: optimal number of treatment cyclesAntonio Rossi, Massimo Di Maio
Health and Quality of Life Outcomes|October 4, 2003
Quality of Life in elderly patients with cancerMassimo Di Maio, Francesco Perrone
Journal of Thoracic Disease|June 29, 2018
A review of guidelines for lung cancerPaolo Bironzo, Massimo Di Maio
Expert Opinion on Pharmacotherapy|January 8, 2010
The role of pemetrexed as maintenance treatment in advanced NSCLC: a Phase III randomized trialCesare Gridelli, Massimo Di Maio
Med (New York, N.Y.)|April 12, 2025
eNRGy: Making progress toward a future for NRG1 fusion-positive cancerLucia Anna Muscarella, Massimo Di Maio
Pageof 42